Govt Job for B.Pharm, B.Sc in Department of Telemedicine PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Applications (with CV) are hereby invited for the different posts in Department of Telemedicine under “Science Technology & Innovation Hub in Leh, Leh Ladakh district, Ladakh (U.T)”.

Project Assistant – One
Qualification/ Eligibility : Graduation in Engineering / Medicine / Pharma or Graduation in Science with one year experience.

Salary : Rs. 22000/- (Consolidated)

Research Associate-I – One
Qualification/ Eligibility : MBBS degree from Indian University Institute recognised by the Medical Council of India or MCI recognised qualification equivalent there to for teaching post. The Candidate must be registered with State Medical Council/MCI.

Salary : Rs.47,600+16%HRA = 55,216/-

Interested candidates can submit their CV by 29.06.2021 till 4 PM, at Department of Telemedicine, Room No 20, 2nd Level, Nehru Hospital or by email (rrcpgimer@gmail.com).

Short listed candidates will be called for the interview on 01.07.2021 at 10 AM. Give your corrected email ID, as all further correspondence will be through email.

At the time of interview, candidates should bring their original certificates for verification. No separate interview letter will be sent and No TA/DA will be paid.

* Those candidate who have already applied for the post of project assistant need not to apply again.

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework